BRIEF published on 06/03/2026 at 19:59, 24 days 7 hours ago Median Technologies Raises €50 Million in Capital Increase Capital Increase Shareholder Base Market Oversubscription Eyonis® Deployment AI-based Diagnostics
PRESS RELEASE published on 06/03/2026 at 19:54, 24 days 7 hours ago Inside Information / Other news releases Median Technologies successfully completes €50 million capital increase without shareholders' preferential subscription rights. Funds to deploy eyonis® LCS in U.S. and Europe and expand clinical indications Investment Capital Increase Median Technologies Eyonis® LCS Clinical Indications
BRIEF published on 05/21/2026 at 17:50, 1 month 6 days ago Median Technologies Publishes Shareholder Meeting Documents Voting Rights Shareholders’ Meeting Euronext Growth Median Technologies Documents Availability
PRESS RELEASE published on 05/21/2026 at 17:45, 1 month 6 days ago Terms of availability of the information and the report on corporate governance Median Technologies releases preparatory documents for the Annual Shareholders’ Meeting on June 10, 2026. Shareholders can access documents on the company's website Shareholders General Meeting Annual Shareholders’ Meeting Preparatory Documents Median Technologies
BRIEF published on 03/30/2026 at 15:19, 2 months 28 days ago Median Technologies Achieves ISO 13485:2016 Certification ISO 13485:2016 Regulatory Standards Oncology Solutions Eyonis® AI-based SaMD
PRESS RELEASE published on 03/30/2026 at 15:14, 2 months 28 days ago Inside Information / Other news releases Median Technologies achieves ISO 13485:2016 certification for eyonis® Medical Device Quality Management System, reinforcing commitment to safe and reliable oncology solutions Median Technologies AI-based Software Oncology Solutions ISO 13485:2016 Certification Eyonis Medical Device
BRIEF published on 02/12/2026 at 22:10, 4 months 15 days ago Median Technologies and Tempus Partner to Expand Lung Cancer Screening in the U.S. FDA Clearance Median Technologies Lung Cancer Screening Eyonis® LCS Tempus AI
PRESS RELEASE published on 02/12/2026 at 22:05, 4 months 15 days ago Inside Information / Other news releases Median Technologies collaborates with Tempus to expand access to eyonis® LCS Software as a Medical Device in the US following FDA 510(k) clearance, enhancing lung cancer screening with AI tools FDA Clearance AI Tools Median Technologies Eyonis® LCS Tempus
BRIEF published on 02/11/2026 at 17:50, 4 months 16 days ago Declaration of the Number of Voting Rights and Shares of Median Technologies Share Capital Voting Rights Treasury Shares Euronext Growth Median Technologies
BRIEF published on 02/11/2026 at 17:50, 4 months 16 days ago Median Technologies Announces Voting Rights Update Voting Rights Shares Treasury Shares Euronext Growth French Regulation
Published on 06/27/2026 at 16:50, 10 hours 55 minutes ago Redwood AI Announces Definitive Agreement with Quantum.IQ and Expands into Quantum Resistant Cyber Security
Published on 06/27/2026 at 01:40, 1 day 2 hours ago Polaris Renewable Energy Announces Results of Director Elections at Annual and Special Meeting
Published on 06/27/2026 at 00:00, 1 day 3 hours ago Onco-Innovations Initiates Three-Species Hepatocyte and Microsome Metabolism Studies for ONC010
Published on 06/26/2026 at 23:00, 1 day 4 hours ago Canadian North Resources Inc. Announces Results of 2026 Annual General and Special Shareholders Meeting
Published on 06/26/2026 at 22:50, 1 day 4 hours ago Banyan Gold Files Technical Report for AurMac Project, Yukon, Canada
Published on 06/27/2026 at 00:05, 1 day 3 hours ago EAN Congress: Hearing aid use linked to 23% lower dementia risk in people with both epilepsy and hearing loss
Published on 06/27/2026 at 00:04, 1 day 3 hours ago Persistent and Nagarro sign Business Combination Agreement to form the Persistent - Nagarro Group, a global leader in AI-led digital engineering
Published on 06/26/2026 at 23:36, 1 day 4 hours ago Persistent and Nagarro sign Business Combination Agreement to form the Persistent – Nagarro Group, a global leader in AI-led digital engineering
Published on 06/26/2026 at 23:36, 1 day 4 hours ago EQS-Adhoc: Nagarro SE: Nagarro signs business combination agreement with Persistent Systems and supports voluntary public takeover offer to all shareholders at EUR 81 per share
Published on 06/26/2026 at 23:27, 1 day 4 hours ago EQS-WpÜG: Takeover Offer / Target company: Nagarro SE; Bidder: Galaxy Germany Holding SE
Published on 06/26/2026 at 07:00, 1 day 20 hours ago Advancing Women’s Health with Rapid Diagnostics: bioMérieux files a Dual 510(k) /CLIA Waiver application to the FDA for the BIOFIRE® SPOTFIRE® Vaginitis Panel
Published on 06/25/2026 at 07:30, 2 days 20 hours ago Gimv signs an agreement to acquire Groupe Cap Vert, France’s leading multi-specialist provider of tree and vegetation critical management services, from Ambienta.
